Previous 10 | Next 10 |
BERKELEY HEIGHTS, N.J., Jan. 04, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that CorMedix managemen...
Image source: The Motley Fool. CorMedix Inc Common Stock (NASDAQ: CRMD) Q3 2021 Earnings Call Nov 09, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: CorMedix Inc Common Stock (CRMD) Q3 2021 Earnings Call Transcript...
CorMedix Inc. (CRMD) Q3 2021 Earnings Conference Call Nov 09, 2021 04:30 PM AM ET Company Participants Dan Ferry - LifeSci Advisors, IR Matt David - Interim CEO, EVP, and CFO Phoebe Mounts - EVP and General Counsel Conference Call Participants Jason Butler - JMP Securities Rohit Bhasin - Need...
CorMedix (NASDAQ:CRMD): Q3 GAAP EPS of -$0.22 misses by $0.04. Revenue of $0.04M (-55.6% Y/Y) beats by $0.04M. Press Release Total cash on hand and short-term investments as of September 30, 2021 was $72.0M, excluding restricted cash of $0.2M. The Company believes that, based on the Company...
BERKELEY HEIGHTS, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced financial results for t...
Baosheng Media Group (NASDAQ:BAOS) +84%. Bone Biologics (OTCPK:BBLG) +36%. Nxt-ID (NASDAQ:NXTD) +34%. SilverBox Engaged Merger (NASDAQ:SBEA) +29% issues letter to investors and partners regarding proposed combination with Black Rifle coffee company Arista Networks ANET +19% add...
BERKELEY HEIGHTS, N.J., Nov. 02, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will report its...
ABVC BioPharma ABVC +233% amid social media buzz Golden Star Resources GSS +18% Chifeng Jilong Gold to buy Golden Star Resources in $470M deal ANI Pharmaceuticals ANIP +15% on Q3 earnings. Archer Aviation (NYSE:ACHR) +11%. DBV Technologies (NASDAQ:DBVT) +13% to h...
BERKELEY HEIGHTS, N.J., Oct. 20, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced the acceptance for pres...
CorMedix (NASDAQ:CRMD) announces changes to its executive leadership team with Khoso Baluch retiring from his role as CEO, effective October 4, 2021, and has also resigned from the Company’s Board of Directors. John Armstrong, EVP for Technical Operations, is retiring from CorMedi...
News, Short Squeeze, Breakout and More Instantly...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BERKELEY HEIGHTS, N.J., July 03, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today announced that it has commenced commercialization of DefenCath ® (tauroli...
BERKELEY HEIGHTS, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that the U.S. Food and Drug Administration (FDA) has...